Hydrolysis of a series of parabens by skin microsomes and cytosol from human and minipigs and in whole skin in short-term culture

被引:89
作者
Jewell, Christopher
Prusakiewicz, Jeffery J.
Ackermann, Chrisita
Payne, N. Ann
Fate, Gwendolyn
Voorman, Richard
Williams, Faith M.
机构
[1] Univ Newcastle, Sch Clin & Lab, Toxicol Unit, Newcastle Upon Tyne NE2 4EA, Tyne & Wear, England
[2] Pfizer Inc, Ann Arbor, MI USA
关键词
parabens; skin; carboxylesterases;
D O I
10.1016/j.taap.2007.08.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Parabens are esters of 4-hydroxybenzoic acid and used as anti-microbial agents in a wide variety of toiletries, cosmetics and pharmaceuticals. It is of interest to understand the dermal absorption and hydrolysis of parabens, and to evaluate their disposition after dermal exposure and their potential to illicit localised toxicity. The use of minipig as a surrogate model for human dermal metabolism and toxicity studies, justifies the comparison of paraben metabolism in human and minipig skin. Parabens are hydrolysed by carboxylesterases to 4-hydroxybenzoic acid. The effects of the carboxylesterase inhibitors paraoxon and bis-nitrophenylphosphate provided evidence of the involvement of dermal carboxylesterases in paraben hydrolysis. Loperamide, a specific inhibitor of human carboxylesterase-2 inhibited butyl- and benzylparaben hydrolysis in human skin but not methylparaben or ethylparaben. These results show that butyl- and benzylparaben are more selective substrates for human carboxylesterase-2 in skin than the other parabens examined. Parabens applied to the surface of human or minipig skin were absorbed to a similar amount and metabolised to 4-hydroxybenzoic acid during dermal absorption. These results demonstrate that the minipig is a suitable model for man for assessing dermal absorption and hydrolysis of parabens, although the carboxylesterase profile in skin differs between human and minipig. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:221 / 228
页数:8
相关论文
共 28 条
[1]   FATE OF FLUAZIFOP BUTYL IN RAT AND HUMAN SKIN INVITRO [J].
CLARK, NWE ;
SCOTT, RC ;
BLAIN, PG ;
WILLIAMS, FM .
ARCHIVES OF TOXICOLOGY, 1993, 67 (01) :44-48
[2]   Comparative in vitro-in vivo percutaneous penetration of the fungicide ortho-phenylphenol [J].
Cnubben, NHP ;
Elliott, GR ;
Hakkert, BC ;
Meuling, WJA ;
van de Sandt, JJM .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2002, 35 (02) :198-208
[3]   Hydrolysis of pyrethroids by human and rat tissues: Examination of intestinal, liver and serum carboxylesterases [J].
Crow, J. Allen ;
Borazjani, Abdolsamad ;
Potter, Philip M. ;
Ross, Matthew K. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 221 (01) :1-12
[4]  
Dabre P. D., 2004, J APPL TOXICOL, V24, P5
[5]  
Harville Heather M, 2007, Drug Metab Lett, V1, P17, DOI 10.2174/187231207779814300
[6]   Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration [J].
Imai, T ;
Yoshigae, Y ;
Hosokawa, M ;
Chiba, K ;
Otagiri, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03) :1234-1242
[7]   Human carboxylesterase isozymes: Catalytic properties and rational drug design [J].
Imai, Teruko .
DRUG METABOLISM AND PHARMACOKINETICS, 2006, 21 (03) :173-185
[8]   Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine [J].
Imai, Teruko ;
Taketani, Megumi ;
Shii, Mayumi ;
Hosokawa, Masakiyo ;
Chiba, Kan .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (10) :1734-1741
[9]  
JEWELL C, 2007, DRUG METAB DISPOS
[10]   Inter-individual variability in esterases in human liver [J].
Jewell, Christopher ;
Bennett, Phillippa ;
Mutch, Elaine ;
Ackermann, Chrisita ;
Williams, Faith M. .
BIOCHEMICAL PHARMACOLOGY, 2007, 74 (06) :932-939